217 related articles for article (PubMed ID: 15902342)
1. Therapeutic leukapheresis in hyperleukocytic leukaemias--the experience of a tertiary institution in Singapore.
Tan D; Hwang W; Goh YT
Ann Acad Med Singap; 2005 Apr; 34(3):229-34. PubMed ID: 15902342
[TBL] [Abstract][Full Text] [Related]
2. Leukapheresis in acute myeloid leukemia patients with hyperleukocytosis: A single center experience.
Berber I; Kuku I; Erkurt MA; Kaya E; Bag HG; Nizam I; Koroglu M; Ozgul M; Bazna S
Transfus Apher Sci; 2015 Oct; 53(2):185-90. PubMed ID: 25843763
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic leukocytapheresis in infants and children with leukemia and hyperleukocytosis: A single institution experience.
Thapa N; Pham R; Cole C; Meinershagen M; Bowman PW; Ray A
J Clin Apher; 2018 Jun; 33(3):316-323. PubMed ID: 29193219
[TBL] [Abstract][Full Text] [Related]
4. Hyperleukocytosis and leukocytapheresis in acute leukaemias: experience from a single centre and review of the literature of leukocytapheresis in acute myeloid leukaemia.
Bruserud Ø; Liseth K; Stamnesfet S; Cacic DL; Melve G; Kristoffersen E; Hervig T; Reikvam H
Transfus Med; 2013 Dec; 23(6):397-406. PubMed ID: 23919332
[TBL] [Abstract][Full Text] [Related]
5. Hyperleukocytosis, leukostasis and leukapheresis: practice management.
Ganzel C; Becker J; Mintz PD; Lazarus HM; Rowe JM
Blood Rev; 2012 May; 26(3):117-22. PubMed ID: 22364832
[TBL] [Abstract][Full Text] [Related]
6. Leukocytoreduction for acute leukemia.
Porcu P; Farag S; Marcucci G; Cataland SR; Kennedy MS; Bissell M
Ther Apher; 2002 Feb; 6(1):15-23. PubMed ID: 11886572
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic leukapheresis in patients with leukostasis secondary to acute myelogenous leukemia.
De Santis GC; de Oliveira LC; Romano LG; Almeida Prado Bde P; Simoes BP; Rego EM; Covas DT; Falcao RP
J Clin Apher; 2011; 26(4):181-5. PubMed ID: 21574176
[TBL] [Abstract][Full Text] [Related]
8. Early Complications of Hyperleukocytosis and Leukapheresis in Childhood Acute Leukemias.
Abla O; Angelini P; Di Giuseppe G; Kanani MF; Lau W; Hitzler J; Sung L; Naqvi A
J Pediatr Hematol Oncol; 2016 Mar; 38(2):111-7. PubMed ID: 26794706
[TBL] [Abstract][Full Text] [Related]
9. Leukocytapheresis for patients with acute myeloid leukemia presenting with hyperleukocytosis and leukostasis: a contemporary appraisal of outcomes and benefits.
Shallis RM; Stahl M; Bewersdorf JP; Hendrickson JE; Zeidan AM
Expert Rev Hematol; 2020 May; 13(5):489-499. PubMed ID: 32248712
[No Abstract] [Full Text] [Related]
10. Leukapheresis in childhood acute leukemias: single-center experience.
Yilmaz D; Karapinar B; Karadaş N; Duyu M; Yazici P; Ay Y; Balkan C; Aydinok Y; Kavakli K
Pediatr Hematol Oncol; 2014 May; 31(4):318-26. PubMed ID: 23988130
[TBL] [Abstract][Full Text] [Related]
11. Leukocytapheresis for the treatment of hyperleukocytosis secondary to acute leukemia.
Aqui N; O'Doherty U
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):457-60. PubMed ID: 25696894
[TBL] [Abstract][Full Text] [Related]
12. Effect of prophylactic leukapheresis on early mortality and overall survival in acute leukemia patients with hyperleukocytosis.
Göçer M; Kurtoğlu E
Ther Apher Dial; 2021 Oct; 25(5):697-703. PubMed ID: 33686785
[TBL] [Abstract][Full Text] [Related]
13. How we approach a patient with symptoms of leukostasis requiring emergent leukocytapheresis.
Pham HP; Schwartz J
Transfusion; 2015 Oct; 55(10):2306-11; quiz 2305. PubMed ID: 26267387
[TBL] [Abstract][Full Text] [Related]
14. Leukapheresis do not improve early death rates in acute myeloid leukemia patients with hyperleukocytosis.
Malkan UY; Ozcebe OI
Transfus Apher Sci; 2017 Dec; 56(6):880-882. PubMed ID: 29153308
[TBL] [Abstract][Full Text] [Related]
15. [Leukapheresis in children with chronic myeloid leukemia and pulmonary leukostasis].
Bubała H; Sońta-Jakimczyk D; Janik-Moszant A; Szczepański T; Tomaszewska R; Drybańska B; Sierantowicz-Zdaniewicz U; Frankiewicz E
Pol Merkur Lekarski; 2004 Nov; 17(101):500-2. PubMed ID: 15754643
[TBL] [Abstract][Full Text] [Related]
16. Comparing leukapheresis protocols for an AML patient with symptomatic leukostasis.
Cline A; Jajosky R; Shikle J; Bollag R
J Clin Apher; 2018 Jun; 33(3):396-400. PubMed ID: 28940295
[TBL] [Abstract][Full Text] [Related]
17. Correlation between expression of CD56/NCAM and severe leukostasis in hyperleukocytic acute myelomonocytic leukaemia.
Novotny JR; Nückel H; Dührsen U
Eur J Haematol; 2006 Apr; 76(4):299-308. PubMed ID: 16519701
[TBL] [Abstract][Full Text] [Related]
18. Leukapheresis treatment in elderly acute leukemia patients with hyperleukocytosis: A single center experience.
Berber I; Erkurt MA; Kuku I; Kaya E; Gozukara Bag H; Nizam I; Koroglu M; Yigit A; Ozgul M
J Clin Apher; 2016 Feb; 31(1):53-8. PubMed ID: 26011305
[TBL] [Abstract][Full Text] [Related]
19. The effect of therapeutic leukapheresis on early complications and outcomes in patients with acute leukemia and hyperleukocytosis: a propensity score-matched study.
Choi MH; Choe YH; Park Y; Nah H; Kim S; Jeong SH; Kim HO
Transfusion; 2018 Jan; 58(1):208-216. PubMed ID: 28960357
[TBL] [Abstract][Full Text] [Related]
20. The role of therapeutic leukapheresis in hyperleukocytotic AML.
Pastore F; Pastore A; Wittmann G; Hiddemann W; Spiekermann K
PLoS One; 2014; 9(4):e95062. PubMed ID: 24733550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
